Xcout Intel
CroiValve
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
Subscribe to see CroiValve’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CroiValve at a glance
CroiValve is a medical devices company headquartered in Ireland. Xcout tracks 12 named people at CroiValve, including Jaime Wheeler (CEO).
CroiValve leadership
- Jaime WheelerCEO
- Dr Lucy O’KeeffeCOO
- Shauna ClarkeCFO
- Dr Martin QuinnCMO
- Gavin KennyManagement Team
- Helen ScotchManagement Team
6 more named people on record for CroiValve, with roles, board committees and tenure — see the full roster →
CroiValve competitors
A few of CroiValve's closest competitors — see the full list of competitors and alternatives →
Coramaze Technologies is a clinical and pre-commercial stage medical device company founded in 2013, with offices in Germany and Israel. The company is focused on developing an innovative transcatheter tricuspid valve repair system called TriPair.
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
TRiCares is a medical device company with global offices that designs and develops specialized structural heart treatments and catheter-based valve repair systems.
Vivasure Medical is an Irish medical-device company developing the Vivasure PerQseal, a sutureless, absorbable closure device for large-bore femoral vascular access sites. It serves clinicians performing transcatheter cardiovascular and other endovascular procedures, including interventional cardiology and radiology.
Capstan Medical is a medical-device company developing minimally invasive, catheter-based systems for transcatheter mitral valve replacement. Its technology is intended for patients with mitral valve disease and the clinicians who treat them, particularly those who may be at elevated risk for open-heart surgery.
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
Get CroiValve's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CroiValve in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access